Journal
STATISTICS IN BIOPHARMACEUTICAL RESEARCH
Volume 12, Issue 2, Pages 187-198Publisher
AMER STATISTICAL ASSOC
DOI: 10.1080/19466315.2019.1697738
Keywords
Fleming-Harrington test; Log-rank test; Nonproportional hazards; Oncology trial; Survival analysis
Ask authors/readers for more resources
The log-rank test is most powerful under proportional hazards (PH). In practice, non-PH patterns are often observed in clinical trials, such as in immuno-oncology; therefore, alternative methods are needed to restore the efficiency of statistical testing. Three categories of testing methods were evaluated, including weighted log-rank tests, Kaplan-Meier curve-based tests (including weighted Kaplan-Meier and restricted mean survival time), and combination tests (including Breslow test, Lee's combo test, and MaxCombo test). Nine scenarios representing the PH and various non-PH patterns were simulated. The power, Type I error, and effect estimate of each method were compared. In general, all tests control Type I error well. There is not a single most powerful test across all scenarios. In the absence of prior knowledge regarding the underlying or non-PH patterns, the MaxCombo test is relatively robust across patterns. Since the treatment effect changes over time under non-PH, the overall profile of the treatment effect may not be represented comprehensively based on a single measure. Thus, multiple measures of the treatment effect should be prespecified as sensitivity analyses to describe the totality of the data. for this article are available online.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available